Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-14

Clinical Trial Update: TMJ-1001 Bruxism Run-In/Pivotal Trial [NA]

View source ↗

Summary

A clinical trial for TMJ-1001 in bruxism has been withdrawn (trial status: withdrawn).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TMJ-1001

Snippet

Sponsor: TMJ Health | Conditions: Bruxism | NA | Status: WITHDRAWN